| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Canaccord Genuity analyst George Gianarikas maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from...
Barclays analyst David Anderson maintains Aspen Aerogels (NYSE:ASPN) with a Underweight and lowers the price target from $6 ...
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading...
Aspen Aerogels (NYSE:ASPN) lowers FY2025 GAAP EPS guidance from $(3.86)-$(3.73) to $(4.15)-$(4.05) vs $(3.82) analyst estimate....
Aspen Aerogels (NYSE:ASPN) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.03...